News
LLY
927.06
-0.91%
-8.52
Healthcare, Financials ETFs Get A Mega-Cap Reset With TRUF, TRUH
Benzinga · 13h ago
How to Play Lilly Stock Post Oral Obesity Pill Foundayo's Approval
NASDAQ · 17h ago
Analysts Offer Insights on Healthcare Companies: PDS Biotechnology (PDSB), Eli Lilly & Co (LLY) and Praxis Precision Medicines (PRAX)
TipRanks · 18h ago
Revisiting Eisai And Biogen's Leqembi Data For Alzheimer's Disease
Seeking Alpha · 18h ago
Trump Trade: U.S. strengthens tariffs on steel, aluminum, copper imports
TipRanks · 20h ago
Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play.
Barron‘s · 20h ago
How Will Skyrizi and Rinvoq Shape AbbVie's Q1 Immunology Sales?
NASDAQ · 22h ago
This Pharma Stock Is Surging 40%. Neurocrine Is Buying It in $2.9 Billion Deal.
Barron‘s · 23h ago
Weekly Report: what happened at LLY last week (0330-0403)?
Weekly Report · 23h ago
Novo Nordisk: Downgrading To 'Sell' As GLP-1 Pipeline Faces Many Risks
Seeking Alpha · 1d ago
Bernstein Remains a Buy on Eli Lilly & Co (LLY)
TipRanks · 1d ago
Analysts Are Bullish on Top Healthcare Stocks: Cigna (CI), Eli Lilly & Co (LLY)
TipRanks · 1d ago
2 Cash-Producing Stocks with Impressive Fundamentals and 1 We Brush Off
Barchart · 1d ago
Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus
Seeking Alpha · 1d ago
Novo Nordisk CEO says weight-loss drug boom has barely begun
Seeking Alpha · 1d ago
Eli Lilly (LLY) Is Up 6.5% After FDA Clears Anytime Oral GLP-1 Foundayo for Obesity Treatment
Simply Wall St · 2d ago
Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight
The Motley Fool · 2d ago
The Next Big AI Winner Might Not Be a Tech Company
Barchart · 2d ago
Build More New Houses
Barron‘s · 3d ago
Eli Lilly (LLY) Valuation Check As Foundayo Oral GLP 1 Approval Lifts Obesity Growth Story
Simply Wall St · 3d ago
More
Webull provides a variety of real-time LLY stock news. You can receive the latest news about Lilly Eli & Co through multiple platforms. This information may help you make smarter investment decisions.
About LLY
Eli Lilly and Company is a medicine company, which discovers, develops, manufactures, and market products in a single business segment called human pharmaceutical products. The Company manufacture and distribute its products through facilities in the United States, including Puerto Rico, and in Europe and Asia. The Company’s products are sold in approximately 90 countries. Its Cardiometabolic Health products Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound, and others. Its oncology products include Cyramza, Erbitux, Tyvyt, Verzenio, Retevmo, Jaypirca, and others. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. Its LillyDirect, a direct-to-patient digital health care platform, provides delivery of select Lilly medicines dispensed by third-party pharmacies to patients.